Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology June 2014 2(6):464-473 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587